PRKAA1 and Alzheimer disease: In addition, recent studies implicate AMPK activity in the pathogenesis of Alzheimer's disease (AD) as a regulator of both tau phosphorylation and amyloidogenesis (Thornton et al., 2011; Vingtdeux et al., 2011).